Tersera Therapeutics

VARUBI

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / VARUBI – J8670

Manufacturer:

Tersera Therapeutics

Name:

VARUBI

HCPCS Code Descriptor:

Rolapitant, oral, 1 mg

Category:

J Code

HCPCS:

J8670

NDC(s):

70720-0101-02

Primary Type:

Oncology-Anti-Emetic

Generic Status:

Single-Source

Route of Administration:

Oral

About:

VARUBI is an Oncology-Anti-Emetic drug manufactured by Tersera Therapeutics and administered via the Oral route of administration. The J Code: J8670 is aligned to the drug VARUBI.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/17

HCPCS Effective Date:

1/1/17

HCPCS Short Description:

Rolapitant, oral, 1mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.varubirx.com/